Another mechanism of SIADH in these patients proposed by Sutton et al is that patients with preeclampsia may have placental abnormalities that impact the production of the placental enzyme vasopressinase that normally would inactivate ADH [17, 18]. This evidence concerns the gene AVP and preeclampsia.